NIT
PTCT icon

NumerixS Investment Technologies’s PTC Therapeutics PTCT Stock Holding History

NumerixS Investment Technologies’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-700
Closed -$36K – 647
2020
Q2 		$36K Sell
700
-2,599
-79% -$128K 0.01% 863
2020
Q1 		$147K Buy
+3,299
New +$166K 0.08% 317
2019
Q3 		– Sell
-2,511
Closed -$113K – 1185
2019
Q2 		$113K Sell
2,511
-2,489
-50% -$98.3K 0.03% 570
2019
Q1 		$182K Buy
5,000
+4,000
+400% +$134K 0.02% 694
2018
Q4 		$32K Buy
+1,000
New +$36K 0.01% 852
2017
Q3 		– Sell
-4,412
Closed -$81K – 1302
2017
Q2 		$81K Buy
+4,412
New +$59.4K 0.01% 875
2016
Q2 		– Sell
-74,647
Closed -$481K – 1221
2016
Q1 		$481K Buy
+74,647
New +$1.3M 0.06% 481
2015
Q3 		– Sell
-6,700
Closed -$322K – 757
2015
Q2 		$322K Buy
+6,700
New +$391K 0.04% 488

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

NumerixS Investment Technologies's PTCT Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of PTC Therapeutics (PTCT) in Q3 2020, closing a stake of 700 shares — an estimated $36K sold.

NumerixS Investment Technologies first reported a position in PTCT in Q2 2015 and held it in 8 quarters. The position peaked at $481K in Q1 2016. 196 funds tracked by Wall St. Rank hold PTCT as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining PTC Therapeutics position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 700 PTC Therapeutics shares in Q3 2020, an estimated $36K.
  • NumerixS Investment Technologies first reported a position in PTC Therapeutics in Q2 2015 and held it in 8 quarters.
  • NumerixS Investment Technologies's PTC Therapeutics position peaked at $481K in Q1 2016.
  • 196 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.